Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2025-12-30 @ 12:39 AM
Study NCT ID:
NCT01421303
Status:
COMPLETED
Last Update Posted:
2014-12-12
First Post:
2011-08-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
Work Productivity In A Cohort Of Employed Ankylosing Spondylitis Patients Treated With Etanercept
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AS@WORK
Brief Summary:
Patients with Ankylosing spondylitis more frequently discontinue work. This study measures the impact of Enbrel on work participation.
Detailed Description:
Purely descriptive
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| B1801053 | OTHER | Alias Study Number | View |